USV Pharma Acquires 79% Stake in Wellbeing Nutrition at ₹1,583 Crore Valuation

StartupTalky News

12 Feb 2026 — 3 min read

USV Pharma Acquires 79% Stake in Wellbeing Nutrition at ₹1,583 Crore Valuation

USV Pharma has entered a major deal to acquire a 79% stake in Wellbeing Nutrition, one of India’s fastest-growing direct-to-consumer (D2C) supplement brands. The all-cash transaction values the company at INR 1,583 crore and marks one of the largest exits in the health and wellness startup space to date.
The acquisition brings together a traditional pharmaceutical leader and a consumer wellness brand at a time when demand for health supplements and preventive care products is rising rapidly.

What the USV-Wellbeing Deal Includes and How the Acquisition Is Structured

Under the agreement, USV Pharma will buy 79% of Nutritionalab Pvt Ltd, the parent company of Wellbeing Nutrition. This includes 35% from founder Avnish Chhabria and the remaining 44% from existing investors, including Hindustan Unilever (HUL) and Fireside Ventures.

The transaction is expected to be completed by 31 March 2026, subject to customary closing conditions.

Founder Avnish Chhabria and Investors Score Big in Major D2C Exit

Wellbeing Nutrition’s founder, Avnish Chhabria, will receive a substantial payout from the sale of his stake. Reports indicate he could earn around INR 800 crore from the deal, with the option to potentially sell more of his shares over the next few years.

For early investors, the acquisition represents a significant return:
HUL, which initially invested around INR 70 crore in 2022, sold its 19.8% stake to USV for about INR 307 crore — more than a fourfold return.
Fireside Ventures, an early backer since 2021, will also exit with strong returns, having backed the company with roughly INR 27 crore. According to industry data, this will translate into roughly 10x returns on its investment.

Wellbeing Nutrition’s Revenue Growth, Losses and FY27 Targets Explained

Wellbeing Nutrition was founded in 2019 and has quickly built a presence both online and in over 6,000 retail outlets across India. The brand offers a range of products, including whey protein, vitamins, collagen, omega-3 supplements and other nutraceuticals.

In the past two years, the company’s revenue has grown significantly. It reported nearly threefold growth, with revenue rising from INR 42 crore in FY23 to INR 119 crore in FY25. However, the company also posted a net loss of INR 38 crore in FY25, mainly due to investments in brand building and category expansion.

As part of USV Pharma’s plans, Wellbeing Nutrition is now targeting INR 450 crore in revenue by FY27, underlining confidence in future growth.

Why Pharma Giants Are Entering India’s Consumer Wellness Market

This acquisition underlines a growing trend in India’s consumer health and wellness space. Large pharmaceutical and fast-moving consumer goods (FMCG) companies are increasingly looking to expand into preventive and lifestyle-oriented products.

USV Pharma, which has a long history in diabetes and cardiovascular medicines, is broadening its portfolio to include nutraceutical and wellness offerings. Its existing products include prescription brands such as Glycomet and Ecosprin.

Industry analysts say the deal reflects both rising consumer interest in health supplements and a wider appetite from traditional healthcare players to diversify into high-growth consumer categories.

What Comes Next

Once completed, USV Pharma will hold a majority stake in Wellbeing Nutrition, with current leadership expected to continue driving growth under new ownership oversight. The deal is set to close within the next few weeks, barring any delays.

For founders, early investors and the broader D2C ecosystem, this acquisition marks a significant milestone in India’s startup and consumer brand landscape.